Daridorexant Hydrochloride Tablets Approved Marketing Information and Precautions

Daridorexant hydrochloride (Daridorexant) tablets are a new dual-receptor (Orexin 1 and Orexin 2) antagonist, mainly used to treat adult patients with insomnia. Its mechanism of action is by inhibiting Orexin receptors and reducing arousal signals, thereby improving difficulty in falling asleep and waking up at night. The drug has been approved for marketing in China, providing a new drug option for insomnia patients.

The use of DaliRasen Tablets requires attention to individual patient differences and potential risks. When using it for the first time, you should start with the recommended starting dose and gradually adjust the dose under the guidance of a doctor. Patients should avoid driving or operating machinery while taking the medication to prevent drug-induced drowsiness or decreased attention from affecting the safety of daily life. At the same time, patients with severe liver damage or other serious diseases should use it with caution under the guidance of a physician.

In addition, attention should be paid to possible side effects during drug use, such as daytime drowsiness, dizziness, or dry mouth. If obvious discomfort occurs, you should seek medical advice promptly and adjust the dose or discontinue the medication. Patients should also avoid concurrent use with other CNS depressant drugs to reduce the risk of excessive sedation or respiratory depression.

Regarding price information, DaliRasheng is currently on the market in China, but it has not yet been included in medical insurance, making it more inconvenient to purchase. In foreign markets, the price of the European version of the original drug is about more than 2,000 yuan, and there are currently no available generic drugs on the market. Patients should choose formal channels when purchasing drugs to ensure drug quality, and make reasonable arrangements for medication based on their own economic conditions.

Reference materials:https://www.drugs.com/